Who are Calcipotriol plus hydrocortisone ointment's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Calcipotriol plus hydrocortisone ointment vehicle, Calcipotriol plus betamethasone.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/calcipotriol-plus-hydrocortisone-ointment.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Calcipotriol plus hydrocortisone ointment — Competitive Intelligence Brief

Calcipotriol plus hydrocortisone ointment (Calcipotriol plus hydrocortisone ointment) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D analogue plus corticosteroid combination. Area: Dermatology.

phase 3 Vitamin D analogue plus corticosteroid combination Vitamin D receptor (VDR) and glucocorticoid receptor (GR) Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Calcipotriol plus hydrocortisone ointment (Calcipotriol plus hydrocortisone ointment) — LEO Pharma. Calcipotriol (a vitamin D analogue) reduces skin cell proliferation and promotes differentiation, while hydrocortisone (a corticosteroid) suppresses inflammation and immune responses in the skin.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Calcipotriol plus hydrocortisone ointment TARGET	Calcipotriol plus hydrocortisone ointment	LEO Pharma	phase 3	Vitamin D analogue plus corticosteroid combination	Vitamin D receptor (VDR) and glucocorticoid receptor (GR)
Calcipotriol plus hydrocortisone ointment vehicle	Calcipotriol plus hydrocortisone ointment vehicle	LEO Pharma	phase 3	Vitamin D analogue plus corticosteroid combination	Vitamin D receptor (VDR); glucocorticoid receptor
Calcipotriol plus betamethasone	Calcipotriol plus betamethasone	LEO Pharma	phase 3	Vitamin D analogue plus corticosteroid combination	Vitamin D receptor (VDR) and glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin D analogue plus corticosteroid combination class)

LEO Pharma · 3 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Calcipotriol plus hydrocortisone ointment — Competitive Intelligence Brief. https://druglandscape.com/ci/calcipotriol-plus-hydrocortisone-ointment. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab